Pacira BioSciences, Inc. (PCRX)

36.48 USD+0.05%close 2026-11-16Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$1.46B52 Week Range: 19.16 – 36.48
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.38.81EPS 0.94
The live quote provider is unreachable; the last known close is shown.

Pacira BioSciences, Inc. (PCRX) is not among the 30 most-held stocks of the tracked superinvestor set. Price 36.48 USD; market cap $1.46B.

Price & valuation

Prev Close36.46
Open—
Day Range—
52 Week Range19.16 – 36.48
Volume—
Avg Volume (3M)—
Market Cap$1.46BSEC 10-Q, 11/04/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.582 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.38.81SEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.0.94SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own PCRX?

Pacira BioSciences, Inc. (PCRX) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on PCRX bullish or bearish?

PCRX is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.